-
2
-
-
0036673445
-
Mathematical modeling for breast cancer assessment: State of art and role in medicine
-
Rubinstein WS, O'Neill SM, Peters JA, Rittmeyer LJ, Stadler MP. Mathematical modeling for breast cancer assessment: state of art and role in medicine. Oncology. 2002;16(8):1082-1094.
-
(2002)
Oncology
, vol.16
, Issue.8
, pp. 1082-1094
-
-
Rubinstein, W.S.1
O'Neill, S.M.2
Peters, J.A.3
Rittmeyer, L.J.4
Stadler, M.P.5
-
3
-
-
24644456397
-
-
US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [published correction appears in Ann Intern Med. 2005;143(7):547]. Ann Intern Med. 2005;143(5):355-361.
-
US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [published correction appears in Ann Intern Med. 2005;143(7):547]. Ann Intern Med. 2005;143(5):355-361.
-
-
-
-
4
-
-
0032537990
-
Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
-
Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998;90(18):1371-1388.
-
(1998)
J Natl Cancer Inst
, vol.90
, Issue.18
, pp. 1371-1388
-
-
Fisher, B.1
Costantino, J.P.2
Wickerham, D.L.3
-
5
-
-
85136390255
-
-
Vogel VG, Costantino JP, Wickerham DL, National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of Tamoxifen vs Raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA. 2006 Jun 21;295(23):2727-2741. Epub 2006 Jun 5.
-
Vogel VG, Costantino JP, Wickerham DL, National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of Tamoxifen vs Raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA. 2006 Jun 21;295(23):2727-2741. Epub 2006 Jun 5.
-
-
-
-
6
-
-
84900372781
-
-
US Food and Drug Administration, Center for Devices and Radiologic Health. Mammography: information for mammography facility personnel, inspectors, and consumers about the implementation of the Mammography Quality Standards Act of 1992 (MQSA). http://www.fda.gov/cdrh/mammography. Accessed March 5, 2008.
-
US Food and Drug Administration, Center for Devices and Radiologic Health. Mammography: information for mammography facility personnel, inspectors, and consumers about the implementation of the Mammography Quality Standards Act of 1992 (MQSA). http://www.fda.gov/cdrh/mammography. Accessed March 5, 2008.
-
-
-
-
7
-
-
84900355131
-
-
National Council on Radiation Protection and Measurements (NCRP). Report No. 149. A Guide to Mammography and Other Breast Imaging Procedures. Issued December 31, 2004. http://www.knovel.com/web/portal /basic_search/display?_EXT_KNOVEL_DISPLAY_bookid=1635. Accessed March 6, 2008.
-
National Council on Radiation Protection and Measurements (NCRP). Report No. 149. A Guide to Mammography and Other Breast Imaging Procedures. Issued December 31, 2004. http://www.knovel.com/web/portal /basic_search/display?
-
-
-
-
8
-
-
0037404722
-
Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666
-
Berg WA. Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666. AJR Am J Roentgenol. 2003;180(5):1225-1228.
-
(2003)
AJR Am J Roentgenol
, vol.180
, Issue.5
, pp. 1225-1228
-
-
Berg, W.A.1
-
10
-
-
0035861037
-
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
-
King M, Wieand S, Hale K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA. 2001;286(18):2251-2256.
-
(2001)
JAMA
, vol.286
, Issue.18
, pp. 2251-2256
-
-
King, M.1
Wieand, S.2
Hale, K.3
-
11
-
-
0037015185
-
Breast cancer screening: A summary of the evidence for the US Preventive Services Task Force
-
Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137(5, pt 1):347-360.
-
(2002)
Ann Intern Med
, vol.137
, Issue.5 and PART 1
, pp. 347-360
-
-
Humphrey, L.L.1
Helfand, M.2
Chan, B.K.S.3
Woolf, S.H.4
-
12
-
-
0031842673
-
Radiation risk of mammography related to benefit in screening programmes: A favourable balance?
-
Beemsterboer PM, Warmerdam PG, Boer R, de Koning HJ. Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J Med Screen. 1998;5(2):81-87.
-
(1998)
J Med Screen
, vol.5
, Issue.2
, pp. 81-87
-
-
Beemsterboer, P.M.1
Warmerdam, P.G.2
Boer, R.3
de Koning, H.J.4
-
13
-
-
0031322032
-
Radiation risk from screening mammography of women aged 40-49 years
-
Feig SA, Hendrick RE. Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr. 1997;(22):119-124.
-
(1997)
J Natl Cancer Inst Monogr
, vol.22
, pp. 119-124
-
-
Feig, S.A.1
Hendrick, R.E.2
|